Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Shares of Sun Pharmaceuticals on Thursday  fell sharply by nearly 7 per cent in early trade, after the pharmaceutical major and Israel's Teva agreed to pay a sum of $2.15 billion to Pfizer......

Sun Pharma in talks to buy Meda for $5-$6 billion

Sun Pharmaceutical Industries Ltd is in talks to buy Swedish drugmaker MedaAB for $5 billion-$6 billion to boost its generics business in developed markets, two sources with direct knowledge of the......

Markets remain firm, Tata Motors top gainer

Benchmark Indices are trading on a higher note led by Auto, Metal and Oil & Gas shares.Meanwhile, building confidence that the US will reach a budget deal with Congress to avoid fiscal cliff has......

It's destination India for Japan Inc!

India has become the most sought destination for investment by Japanese companies, next to China, and ahead of other Asian countries and emerging economies like Russia, Brazil, Mexico and even the......